Bio-Rad Laboratories Inc (BIO NYSE) stock market data APIs
$312.5103
6.98(2.2%)
as of November 3, 2025
Try our APIs with
free plan!
Bio-Rad Laboratories Inc Financial Data Overview
Price chart is built with
Anychart
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Prev. Close
312.5103
Open
319.4933
High
318.4544
Low
306.959
52 wk Range
211.43-387.99
Market Cap
8 320 M
Shares Outstanding
21 906 K
Revenue
2 557 M
EPS
2.26
Beta
0.969
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Bio-Rad Laboratories Inc (top by weight)
Ticker
100-day Price Change
Weight
EAASX.US
EATON VANCE ATLANTA CAPITAL SMID-CAP FUND EATON VANCE ATLANTA CAPITAL SMID-CAP FUND CLASS A
-3.29
(-9.26%)
3.08
GMVM.F
VanEck Vectors UCITS ETFs plc - VanEck Vectors Morningstar US Wide Moat UCITS ETF
1.76
(3.33%)
2.53
MDEV.US
First Trust Exchange-Traded Fund VI - First Trust Indxx Medical Devices ETF
-0.51
(-2.46%)
1.99
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bio-Rad Laboratories Inc data using free add-ons & libraries
Get Bio-Rad Laboratories Inc Fundamental Data
Bio-Rad Laboratories Inc Fundamental data includes:
- Net Revenue: 2 557 M
- EBITDA: 418 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-30
- EPS/Forecast: 1.94
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bio-Rad Laboratories Inc News
New
HbA1c Testing Market Research Report 2025-2033, Profiles of Key Players - Danaher, F. Hoffmann-La Roche, Siemens, Abbott, Bio-Rad Laboratories, ARKRAY, Trinity Biotech, EKF Diagnostics
Company Logo The HbA1c testing market presents opportunities driven by rising Type 2 diabetes cases and advancements in testing technologies. Supportive healthcare initiatives and increased awareness...
Is Bio-Rad’s Earnings Miss and Biodesix Partnership Redefining the Investment Outlook for BIO?
On October 29, 2025, Bio-Rad Laboratories reported third-quarter earnings with sales of US$653 million and a net loss of US$341.9 million, while also completing a major share repurchase and announcing...
Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls
Bio-Rad Laboratories, Inc. BIO posted third-quarter 2025 adjusted earnings per share (EPS) of $2.26, which missed the Zacks Consensus Estimate by 1.74%. However, the bottom line increased 11.9% from t...
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
Biodesix, Inc. Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher Scientific L...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
